DES Follow-up Clinic
Monitoring women whose mothers took the drug Diethyl Stilboestrol (DES) during their pregnancy.
For women whose mothers took the drug Diethyl Stilboestrol (DES) during their pregnancy we provide the following services:
- Colposcopy of cervix and vagina
- Gynaecological assessment
- Management of menopausal issues
- Women whose mothers took DES during their pregnancy
- The grand-daughters will be seen only if they request it
- Who took DES
- Whose mothers did not take DES during their pregnancy
The women will attend an annual follow up unless an abnormality is found on a pap smear and then followed up more frequently.
Triage staff may assign your referral to a clinic with a shorter waiting time and most appropriate speciality focus. More comprehensive referrals are usually seen more quickly.
Please include "History of DES exposure in utero" in your referral*
* often history is uncertain and patients want clarification as to whether she is likely to be exposed or not.
Please complete and fax the Fast Fax Referral form
Please contact Dr Ross Pagano directly for all DES related issues.
An acknowledgement letter will be sent directly to the patient and the GP will be notified. The patient will then receive a letter with the appointment details.
Clinic are held in Ross Pagano’s private rooms at the Women’s – he is the sole consultant for the clinic. Consultations are free of charge.
This information is for women who have recently been informed that they may have been exposed to DES (di-ethyl-stilboestrol or stilboestrol). This DES exposure fact sheet discusses the importance of being under the care of medical professionals experienced in DES exposed women and the treatments and examinations they will need.
- DES exposure
A colposcopy is an examination which is recommended after some positive or abnormal cervical screening test results. Your local doctor (GP) will discuss these results with you. After a colposcopy, decisions can be made about whether treatment is needed or not.